---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-211269"
form_type: "8-K"
ticker: "AMGN"
cik: "0000318154"
company_name: "AMGEN INC"
filed_at: "2022-08-03T23:59:59+00:00"
generated_at: "2026-06-24T05:29:29.473972+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Amgen appoints Michael V. Drake to Board of Directors effective August 3, 2022

## Summary
- Dr. Drake is president of the University of California, with medical and academic leadership background.
- Board now has 13 directors, 12 of whom are independent.
- He will serve on the Corporate Responsibility & Compliance and Governance & Nominating Committees.
- Standard director compensation includes pro-rated annual retainer of $105,000, committee retainer of $12,500, and RSU grant valued at $210,000.
- No arrangements or transactions exist between Dr. Drake and Amgen.

## SEC filing metadata
- accession: 0001193125-22-211269
- form_type: 8-K
- ticker: AMGN
- cik: 0000318154
- company_name: AMGEN INC
- filed_at: 2022-08-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318154/000119312522211269/0001193125-22-211269-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318154/000119312522211269/d386700d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-211269
- JSON: https://secwatch.observer/filing/0001193125-22-211269.json
- Plain text: https://secwatch.observer/filing/0001193125-22-211269.txt

## Key facts
- Executive change
  Michael V. Drake was appointed as director at AMGEN INC.
  - Action: appointed
  - Role: director
  source text: On August 3, 2022, the Board of Directors (the “Board”) of Amgen Inc. (the “Company”) appointed Michael V. Drake as a director of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/318154/000119312522211269/0001193125-22-211269-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.